Gohealth, INC 8-K filings

GoHealth, Inc. has successfully completed its financial restructuring and emerged from Chapter 11 bankruptcy, transitioning to private ownership with a strengthened financial position.

GoHealth, Inc. has received a delisting notice from Nasdaq due to its Chapter 11 bankruptcy filing, with trading to be suspended on June 16, 2026.

GoHealth, Inc. has filed for voluntary Chapter 11 bankruptcy to implement a prepackaged plan supported by key stakeholders, aiming to continue operations and strengthen its financial position.

GoHealth, Inc. announced its full-year 2025 financial results, revealing an intentional pullback in Medicare Advantage activity and a focus on consumer fit, renewal economics, and cash discipline.

GoHealth, Inc. received a Nasdaq notice for non-compliance with listing rules, including minimum market value, stockholders' equity, and net income requirements.

GoHealth reports Q3 2025 results, detailing an intentional reduction in Medicare Advantage volume and a focus on retention and strategic flexibility in a rationalizing market.

GoHealth, Inc. announced the appointment of Mark Weinsten and Bao Truong to its Board of Directors, while Jeremy W. Gelber and Abhiraj Modi resigned.

GoHealth, Inc. has completed a significant financial restructuring, securing new superpriority debt and issuing a substantial equity stake to lenders to enhance liquidity and financial flexibility.

GoHealth, Inc. has amended its existing credit agreement to extend the maturity of its Class A Revolving Commitments to September 30, 2025, waive certain financial covenants, and permit a receivables financing, as it works to address its recent going concern position.

GoHealth, Inc. announced that all four proposals, including the election of three Class II directors and the ratification of Ernst & Young LLP as its independent auditor, were approved by stockholders at its 2025 Annual Meeting.

GoHealth announces a strong first quarter in 2025, with significant improvements in revenue, net loss, and Adjusted EBITDA.

GoHealth, Inc. has extended CEO Vijay Kotte's employment agreement by three years, increased his base salary to $1,000,000, and granted him significant equity and cash retention awards.

GoHealth, Inc. announced strong financial results for Q4 and fiscal year 2024, driven by a successful Annual Enrollment Period, with significant growth in revenue, submissions, and adjusted EBITDA.

GoHealth's third quarter results show a significant improvement in net income and positive cash flow, driven by strategic acquisitions and cost management, despite a slight revenue decrease.

GoHealth, Inc. has appointed Brendan Shanahan as its new Chief Financial Officer, effective October 14, 2024, while Katherine O'Halloran will continue with the company as Chief Accounting Officer.

GoHealth has completed its acquisition of e-TeleQuote, adding over $100 million in contract assets and $18 million in cash, while expanding its agent network.

GoHealth, Inc. is set to acquire e-TeleQuote Insurance, Inc., a move that will significantly expand its position in the Medicare insurance marketplace.

GoHealth's second quarter results show a decrease in revenue and submissions, but an improvement in net loss compared to the same period last year.

GoHealth has appointed Alan Wheatley, former President of Medicare at Humana, and Abhiraj Modi, Managing Director at Centerbridge Partners, to its Board of Directors, while Christopher Litchford has resigned.

GoHealth, Inc. announces the resignation of director Joseph G. Flanagan, effective June 25, 2024, and the appointment of Alexander Timm as the new lead independent director.

GoHealth, Inc. has amended its previous 8-K filing to include details of the compensation package for Interim Chief Financial Officer, Katherine OHalloran.

GoHealth, Inc. held its 2024 Annual Meeting of Stockholders on June 12, 2024, where three Class I directors were elected and two proposals were approved.

GoHealth's Chief Financial Officer, Jason Schulz, has resigned for personal reasons, and Chief Accounting Officer, Katherine O'Halloran, has been appointed as interim CFO while a search for a permanent replacement is conducted.

GoHealth's first quarter 2024 results show a slight revenue increase and a reduced net loss, highlighting the company's focus on consumer-centric strategies.

GoHealth's 2023 financial results show a substantial improvement in cash flow from operations and profitability, driven by a shift to a non-agency operating model and a focus on consumer engagement.

GoHealth's 2023 financial results show significant improvements in cash flow and profitability, driven by a strategic shift towards a non-agency operating model.